Cutaneous squamous cell carcinoma and human papillomavirus;Carcinoma espinocelular cutáneo y papilomavirus (VPH)

Actas Dermo-Sifiliograficas

Volumn 98, Issue 9, 2007, Pages 583-593

  Corbalán Vélez, Raúl ^a   Ruiz Macia J A ^b   Brufau, C ^c   Carapeto, F J ^d  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL VEGA BAJA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Epidermodysplasia verruciformis; HPV; Human papillomavirus; Skin; Squamous cell carcinoma

Indexed keywords

PSORALEN;

CARCINOGENESIS; CONDYLOMA ACUMINATUM; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; ONCOGENE; PROGNOSIS; PSORIASIS; PUVA; REVIEW; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; UTERINE CERVIX CARCINOMA; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMANS; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS;

EID: 37249090172     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(07)70523-1     Document Type: Review

References (134)

1. De Villiers EM. Taxonomic classification of papillomaviruses. Papillomavirus Report. 2001; 12: 57-63.
2. Chan SY, Delius H, Halpern AL, Bernard HU. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny and taxonomy. J Virol. 1995; 69: 3074-83.
3. de Jong-Tieben LM, Berkhout RJ, ter Schegget J, Vermeer BJ, de Fijter JW, Bruijn JA, et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation. 2000;69:44-9.
4. Berkhout RJ, Bouwes Bavinck JN, ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol. 2000;38:2087-96.
5. Egawa K. New types of human papillomaviruses and intracytoplasmic inclusion bodies: a classification of inclusion warts according to clinical features, histology and associated HPV types. Br J Dermatol. 1994;130:158-66.
6. Gross G, Pfister H, Hagedorn M, Gissmann L. Correlation between human papillomavirus (HPV) type and histology of warts. J Invest Dermatol. 1982;78:160-4.
7. Jablonska S, Orth G, Obalek S, Croissant O. Cutaneous warts. Clinical, histologic and virologic correlations. Clin Dermatol. 1985;3:71-82.
8. Androphy EJ. Molecular biology of human papillomavirus infection and oncogenesis. J Invest Dermatol. 1994;103:248-56.
9. Weedon D. Viral diseases. In: Weedon D, editor. Skin Pathology. New York: Churchill Livingstone Ed; 1998. p.583-603.
10. Grayson W, Calonje E, McKee PhH. Infections diseases of the skin. In: McKee PhH, Calonje E, Granter S, editors. Pathology of the skin with clinical correlations. 3rd ed. Philadelphia: Elsevier Mosby Ed; 2005. p.838-50.
11. Villarrubia VG, Costa LA, Pérez M, Vidal S, Jaen P. Epidemiología e inmunopatogenia del cáncer cutáneo no melanoma. El papel iniciador y promotor del VPH. Piel. 2001;16:428-38.
12. Astori G, Lavergne D, Benton C, Hockmayr B, Egawa K, Garbe C, et al. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol. 1998;110:752-5.
13. Howley PM. The role of papillomaviruses in human cancer. In: De Vita V, Hellman S, Rosenberg SA, editors. Important advances in oncology. Philadelphia: Lippincott Ed; 1987. p.55-73.
14. Shelley WB, Wood MG. Transformation of the common wart into squamous cell carcinoma in a patient with primary lymphedema. Cancer. 1981;48:820-4.
15. Noel JC, Peny MO, Goldschmidt D, Verhest A, Heenen M, de Dobbeleer G. Human papillomavirus type 1 DNA in verrucous carcinoma of the leg. J Am Acad Dermatol. 1993;29:1036-8.
16. Kopelson PL, Nguyen QH, Moy RL. Verruca vulgaris and radiation exposure are associated with squamous cell carcinoma of the finger. J Dermatol Surg Oncol. 1994;38-41.
17. Echt AF, Hurwitz RM, Davis TE. Warts: benign or malignant? Indiana Med. 1991;84:476-9.
18. Milburn PB, Brandsma JL, Goldsman CI, Teplitz ED, Heilman EI. Disseminated warts and evolving squamous cell carcinoma in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1988;19:401-5.
19. Philips ME, Ackerman AB. «Benign» and «malignant» neoplasms associated with verrucae vulgares. Am J Dermatopathol. 1982;4:61-84.
20. Castaño-Suárez E, Guerra-Tapia A, Iglesias-Díez L, Llamas-Martín R, Picazo-Garza JJ, Postigo-Llorente C, et al. Detección y tipado de Papillomavirus humano en raspados de pacientes infectados por el virus de la inmunodeficiencia humana. Actas DermoSifiliogr. 2003;94:17-23.
21. Acosta-Dibarraz G, González-Domínguez V, Paciel-Vaz J, Vignale-Peirano R. Presencia del virus del papiloma humano en lesiones de liquen escleroso y atrofico vulvar. Estudio por inmunohistoquimica e hibridización in situ. Actas DermoSifiliogr. 2002;93:389-92.
22. Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, et al. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer. 2002;87:61-4.
23. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-65.
24. Ahmed AM, Madkan V, Tyring SK. Human papillomaviruses and genital disease. Dermatol Clin. 2006;24:157-65.
25. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467-75.
26. Major T, Szarka K, Sziklai I, Gergely L, Czegledy J. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol. 2005;58: 51-5.
27. Gushi A, Kanekura T, Kanzaki T, Eizuru Y. Detection and sequences of human papillomavirus DNA in nongenital seborrhoeic keratosis of immunocompetent individuals. J Dermatol Sci. 2003;31:143-9.
28. Rice PS, Mant C, Cason J, Bible JM, Muir P, Kell B, et al. High prevalence of human papillomavirus type 16 infection among children. J Med Virol. 2000;61:70-5.
29. Clavel CE, Pham-Huu V, Durlach AP, Birembaut PL, Bernard PM, Derancourt CG. Mucosal oncogenic human papillomaviruses and extragenital Bowen disease. Cancer. 1999;86:282-7.
30. Pham-Huu V, Derancourt C, Clavel C, Durlach A, Birembaut P, Bernard P. Oncogenic mucosal human papillomaviruses in Bowen's disease of the hands. Ann Dermatol Venereol. 1999;126:808-12.
31. Mitsuishi T, Sata T, Matsukura T, Iwasaki T, Kawashima M. The presence of mucosal human papillomavirus in Bowen's disease of the hands. Cancer 1997;79:1911-7.
32. Boxman IL, Russell A, Mulder LH, Bavinck JN, Schegget JT, Green A. Case-control study in subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. Int J Cancer. 2000;86:118-21.
33. Meyer T, Arndt R, Christophers E, Nindl I, Stockfleth E. Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev. 2001;25:533-47.
34. Meyer T, Arndt R, Christophers E, Stockfleth E. Frequency and distribution of HPV types detected in cutaneous squamous-cell carcinomas depends upon the HPV detection system: a comparison of four PCR assays. Dermatology. 2000;201:204-11.
35. Iftner A, Klug SJ, Garbe, Blum A, Stancu A, Wilczynski SP, et al. The prevalence of human papillomavirus genotypes in non-melanoma skin cancers of non-immunosuppressed individuals identifies high-risk genital types as posible risk factors. Cancer Res. 2003;63:7515-9.
36. Lampert A, Pauwels C, Duboucher C, Morel G, Poveda JD, Perie G. Détection de papillomavirus humains dans la maladie de Bowen cutanée extragénitale chez le sujet immunocompétent. Ann Dermatol Venereol. 2000;127:40-5.
37. Hama N, Ohtsuka T, Yamazaki S. Detection of mucosal human papilloma virus DNA in bowenoid papulosis, Bowen's disease and squamous cell carcinoma of the skin. J Dermatol. 2006;33:331-7.
38. Derancourt C, Mougin C, Chopard-Lallier M, Coumes-Marquet S, Drobacheff C, Laurent R. Oncogenic human papillomaviruses in extra-genital Bowen disease revelead by in situ hybridization. Ann Dermatol Venereol. 2001;128:715-8.
39. Mitsuishi T, Kawana S, Kato T, Kawashima M. Human papillomavirus infection in actinic keratosis and Bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21 (waf1/cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions. Human Pathol. 2003;34:886-92.
40. Quereux G, N'Guyen JM, Dreno B. Human papillomavirus and extragenital in situ carcinoma. Dermatology. 2004;209:40-5.
41. Sato T, Morimoto A, Ishida Y, Matsuo I. Human papillomavirus associated with Bowen's disease of the finger. J Dermatol. 2004;31:927-30.
42. Zheng S, Adachi A, Shimizu M, Shibata SI, Yasue S, Sakakibara A, et al. Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen's disease. Br J Dermatol. 2005;152:1243-7.
43. Forslund O, Nordin P, Hansson BG. Mucosal human papillomavirus types in squamous cell carcinomas of the uterine cervix and subsequently on the fingers. Br J Dermatol. 2000;142:1148-53.
44. Alam M, Caldwell JB, Eliezri YD. Human papillomavirus-associated digital squamous cell carcinoma: Literature review and report of 21 new cases. J Am Acad Dermatol. 2003;48:385-93.
45. Zabawski EJ jr, Washak RV, Cohen JB, Cockerell CJ, Brown SM. Squamous cell carcinoma of the nail bed: is finger predominance a clue to etiology? A report of 5 cases. Cutis. 2001;67:59-64.
46. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004;31:744-54.
47. Koppikar P, de Villiers EM, Mulherkar R. Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 2005;113:946-50.
48. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005;32Suppl1:S59-66.
49. Castillo A, Aguayo F, Koriyama C, Torres M, Carrascal E, Corvalan A, et al. Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol. 2006;12:6188-92.
50. Farhadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, Malekzadeh R. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol. 2005;11:1200-3.
51. Brouchet L, Valmary S, Dahan M, Didier A, Galateau-Salle F, Brousset P, et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer. 2005;92:743-6.
52. Coissard CJ, Besson G, Polette MC, Monteau M, Birembaut PL, Clavel CE. Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol. 2005;18:1606-9.
53. Torrente MC, Ampuero S, Abud M, Ojeda JM. Molecular detection and typing of human papillomavirus in laringuela carcinoma specimens. Acta Otolaryngol. 2005;125:888-93.
54. Dahlstrand HM, Dalianis T. Presence and influence of human papillomaviruses (HPV) in tonsillar cancer. Adv Cancer Res. 2005;93:59-89.
55. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis. 2002;15:101-14.
56. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol. 2000;61:289-97.
57. Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47:1-17.
58. Fuente MJ, Sabat M, Roca J, Lauzurica R, Fernández-Figueras MT, Ferrandiz C. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol. 2003;149:1221-6.
59. Fortina AB, Piaserico S, Caforio AL, Abeni D, Alaibac M, Angelini A, et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol. 2004;140:1079-85.
60. Lindelof B, Sigurgeirssson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143;614-8.
61. O'Connor DP, Kay EW, Leader M, Murphy GM, Atkins GJ, Mabruk MJ. Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: correlation with human papillomaviruses? Diagn Mol Pathol. 2001;10:190-9.
62. Melo A, Roa I, Montenegro S, Capurro I, Roa JC. Detection of human papillomavirus in cytologic samples or biopsies of the cervix. Rev Med Chil. 2005;133:639-44.
63. Bertelsen BI, Kugarajh K, Skar R, Laerum OD. HPV subtypes in cervical cancer biopsies between 1930 and 2004: detection using general primer pair PCR and sequencing. Virchows Arch. 2006;449:141-7.
64. Sánchez-García VP, Sanz A, Eloy C, Vera A, Martín T, Sánchez-Fajardo F. Epidermodisplasia verruciforme. Actas DermoSifiliogr. 2005;96:531-3.
65. Berger TG, Sawchuk WS, Leonardi C, Langenberg A, Tappero J, Leboit PE. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease. Br J Dermatol. 1991;124:79-83.
66. Tieben LM, Berkhout RJ, Smits HL, Bouves Bavinck JN, Vermeer BJ, Bruijn JA, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus tipes in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol. 1994;131:226-30.
67. Slawsky LD, Gilson RT, Hockley AJ, Libow LF. Epidermodysplasia verruciformis associated with severe immunodeficiency, lymphoma, and disseminated molluscum contagiosum. J Am Acad Dermatol. 1992;27:448-50.
68. Obalek S, Favre M, Szymanczyk J, Misiewicz J, Jablonska S, Orth G. Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients. J Invest Dermatol. 1992;98:936-41.
69. Lutzner MA, Orth G, Dutronquay V, Ducasse MF, Kreis H, Crosnier J. Detection of human papillomavirus type 5 DNA in skin cancers of an immunosupressed renal allograft recipient. Lancet. 1983;2:422-4.
70. Stark S, Petridis AK, Ghim SJ, Jenson AB, Bouwes Bavinck JN, Gross G, et al. Prevalence of antibodies against viruslike particles of epidermodysplasia verruciformis-associated HPV 8 in patients at risk of skin cancer. J Invest Dermatol. 1998;111:696-701.
71. Aubin F, Laurent R. Human papillomavirus-associated cutaneous lesions. Rev Prat. 2006;56:1905-13.
72. Pfister H, Fuchs PG, Majewski S, Jablonska S, Pniewska I, Malejczyk M. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res. 2003;295:273-9.
73. Forslund O, Lindelof B, Hradil E, Nordin P, Stenquist B, Kirnbauer R, et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in «Stripped» biopsies form the same tumors. J Invest Dermatol. 2004;123:388-94.
74. Stockfleth E, Nindl I, Sterry W, Ulrich C, Schmook T, Meyer T. Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg. 2004;30:604-9.
75. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol. 2000;74:11636-41.
76. Aubin F. Mechanism involved in ultraviolet light-induced immunosuppression. Eur J Dermatol. 2003;13:515-23.
77. Carrascosa JM. Efectos de la radiación ultravioleta sobre el sistema inmunitario. Implicaciones terapeúticas. Piel. 2004;19:303-12.
78. Hanneman KK, Cooper KD, Baron ED. Ultraviolet immunosuppression: mechanisms and consequences. Dermatol Clin. 2006;24:19-25.
79. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, et al. Shortage of circulating naive CD8+T cells provides new insights on immunodeficiency in aging. Blood. 2000;95:2860-8.
80. Bouwes Bavinck JN, Feltkamp M, Struijk L, ter Schegget J. Human papillomavirus infection and skin cancer risk in organ transplant recipient. J Investig Dermatol Symp Proc. 2001;6:207-11.
81. Jenson AB, Geyer S, Sundberg JP, Ghim S. Human papillomavirus and skin cancer. J Investig Dermatol Symp Proc. 2001;6:203-6.
82. Weissenborn SJ, Hopfl R, Weber F, Smola H, Pfister HJ, Fuchs PG. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Invest Dermatol. 1999;113:122-6.
83. Wolf P, Seidl H, Bäck B, Binder B, Hofler G, Quehenberger F, et al. Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UVA. Arch Dermatol. 2004;140:317-24.
84. Harwood CA, Spink PJ, Surentheran T, Leigh IM, Hawke JL, Proby CM, et al. Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers. J Invest Dermatol. 1998;111:123-7.
85. Zumtobel U, Schwarze HP, Favre M, Taieb A, Delaunay M. Widespread cutaneous carcinomas associated with human papillomavirus 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients. Dermatology. 2001;202:127-30.
86. Biliris KA, Koumantakis E, Dokianakis DN, Sourvinos G, Spandidos DA. Human papillomavirus infection of nonmelanoma skin cancers in immunocompetent hosts. Cancer Lett. 2000;161:83-8.
87. Harwood CA, Spink PJ, Surentheran T, Leigh IM, de Villiers EM, Mc Gregor JM, et al. Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol. 1999;37:3545-55.
88. Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG. A broad range of human papillomavirus types detected with a general PCR method suitable for analisis of cutaneous tumours and normal skin. J Gen Virol. 1999;80:2437-43.
89. Forslund O, Ly H, Higgins G. Improved detection of cutaneous human papillomavirus DNA by single tube nested «hanging droplet» PCR. J Virolog Methods. 2003;110:129-36.
90. Manos MM, Ting Y, Wright DK. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cel. 1989;7:209-14.
91. Martínez A, Nás R, LaCruz C, Hellín T, Tercero JC, Valverde E, et al. Detección y tipado de papilomavirus humano por amplificación genómica en biopsias, frotis y orina. Acta ginecologica. 1995;52:51-6.
92. Dabic MM, Hlupic L, Babic D, Jukic S, Seiwerth S. Comparison of polymerase chain reaction and catalyzed signal amplification in situ hybridization methods for human papillomavirus detection in paraffin-embedded cervical preneoplastic and neoplastic lesions. Arch Med Res. 2004;35:511-6.
93. Biedermann K, Dandachi N, Trattner M, Vogl G, Doppelmayr H, More E, et al. Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue. J Clin Microbiol. 2004;42:3758-65.
94. Aubin F, Humbey O, Guérrini JS, Mougin C, Laurent R. Cancers cutanés non mélaniques et papillomavirus humains. Ann Dermatol Venereol. 2003;130:1131-8.
95. Zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochem Biophys Acta. 1996;1288:55-78.
96. Masini C, Fuchs PG, Gabrielli F, Stark S, Sera F, Ploner M, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol. 2003;139:890-4.
97. Feltkamp MC, Broer R, di Summa FM, Struijk L, van der Meijden E, Verlaan BP, et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res. 2003;63:2695-700.
98. Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol. 2004;150:949-57.
99. Karagas MR, Nelson HH, Sehr P, Waterboer T, Strukel TA, Andrew A, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst. 2006;98:389-95.
100. Bouwes Bavinck JN, Stark S, Petridis AK, Maruqq ME, ter Schegget J, Westendorp RG, et al. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated human papillomavirus type 8 in patients with actinic keratoses. Br J Dermatol. 2000;42:103-9.
101. Boxman IL, Russell A, Mulder LH, Bavinck JN, ter Schegget J, Green A, et al. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol. 2001;117:1108-12.
102. Purdie KJ, Surentheran T, Sterling JC, Bell L, McGregor JM, Proby CM, et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol. 2005;125:98-107.
103. Hodges A, Smoller BR. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol. 2002;15:1121-5.
104. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppresor and its relatives (review). Biochim Biophys Acta. 1998;1378:115-77.
105. Pavey S, Conroy S, Russel T, Gabrielli B. Ultraviolet radiation induces p16 expression in human skin. Cancer Res. 1999;59:4185-9.
106. Soufir N, Moles JP, Vilmer C, Moch C, Verola O, Rivet J, et al. P16 UV mutations in human skin epithelial tumors. Oncogene. 1999;18:5477-81.
107. Conscience I, Jovenin N, Coissard C, Lorenzato M, Durlach A, Grange F, et al. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol. 2006;16:518-22.
108. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG. In situ detection of the hypermethylation induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA. 1999;96:12754-9.
109. Masumoto N, Fujii T, Ishikawa M, Saito M, Iwata T, Fukuchi T, et al. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Human Pathol. 2003;34:778-83.
110. Hayashi M, Tamura G, Kato N, Ansai S, Kondo S, Motoyama T. Genetic analysis of cutaneous squamous cell carcinomas arising from different areas. Pathol Int. 2003;53:602-7.
111. Dokianakis DN, Koumantaki E, Billiri K, Spandidos DA. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated non-melanoma skin cancers in immunocompetent host. Int J Mol Med. 2000;5:405-9.
112. Quenneville LA, Trotter MJ, Maeda T, Tron VA. P53-dependent regulation of heat shock protein 72. Br J Dermatol. 2002;146:786-91.
113. Padlewska K, Ramoz N, Cassonet P, Riou G, Barrois M, Majewski S, et al. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. J Invest Dermatol.2001;117: 935-42.
114. Jackson S, Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene. 2000;19:592-8.
115. Pfister H, ter Schegget J. Role of HPV in cutaneous premalignant and malignant tumours. Clin Dermatol. 1997;15:335-47.
116. Jackson S, Harwood CA, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Devel. 2000;14:3065-73.
117. Akgul B, García-Escudero R, Ghali L, Pfister HJ, Fuchs PG, Navsaria H, et al. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res. 2005;65:2216-23.
118. Frazer IH, Thomas R, Zhou J, Leggatt GR, Dunn L, McMillan N, et al. Potential strategies utilised by papillomavirus to evade host immunity. Immunol Rev. 1999;168:131-42.
119. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690-8.
120. Zanetti R, Rosso S, Martínez C, Navarro C, Schraub S, Sancho-Garnier H, et al. The multicentre south European study «Helios» I: skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996;73:1440-6.
121. Rosso S, Zanetti R, Martínez C, Torno MJ, Schraub S, Sancho-Garnier H, et al. The multicentre south European study «Helios» II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996;73:1447-54.
122. Rodríguez-Cerdeira C, Alba Menéndez A, Vilata Corell JJ. Desarrollo de nuevas vacunas frente al virus del papiloma humano. Piel. 2007;22:51-3.
123. Villa LL, Costa RL, Petta CA, Andrade RP, Aula KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6:271-8.
124. Papaconstantinou HT, Lee AJ, Simmang CL, Ashfaq R, Gokaslan ST, Sokol S, et al. Screening methods for high-grade dysplasia in patients with anal condyloma. J Surg Res. 2005;127:8-13.
125. Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, et al. Age-related prevalence of anal cancer precursors in homosexual men: the explore study. J Natl Cancer Inst. 2005;97:896-905.
126. Arican O, Guneri F, Bilgic K, Karaoglu A. Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study. J Dermatol. 2004;31:627-31.
127. Umudum H, Rezanko T, Dag F, Dogruluk T. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas. Cancer. 2005;105:171-7.
128. Hoffmann M, Gottschlich S, Gorogh T, Lohrey C, Schwarz E, Ambrosch P, et al. Human papillomaviruses in lymph node neck metastases of head and neck cancers. Acta Otolaryngol. 2005;125:415-21.
129. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24:5623-5.
130. Reimers N, Kasper HU, Weissenborn SJ, Stulzer H, Preuss SF, Hoffmann TK, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007,120:1731-8.
131. Bahnassy AA, Zekri AR, Abdallah S, El-Shehaby AM, Sherif GM. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, CerbB2 and impact on survival. Pathol Int. 2005;55:53-62.
132. Schlecht NF. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: An overview of the evidence. Oncol Rep. 2005;14:1239-47.
133. Kozomara R, Jovic N, Magic Z, Brankovic-Magic M, Minic V. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival. J Craniomaxillofac Surg. 2005;33:342-8.
134. Middelkamp-Hup MA, Pathak MA, Parrado C, Garcia-Caballero T, Rius-Diaz F, Fitzpatrick TB, et al. Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin. J Am Acad Dermatol.2004;50:41-9.